Drug Shortage Report for DILANTIN
| Report ID | 262284 |
| Drug Identification Number | 00022780 |
| Brand name | DILANTIN |
| Common or Proper name | PHENYTOIN SODIUM |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | PHENYTOIN SODIUM |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 1x100 BTL CA |
| ATC code | N03AB |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2025-07-07 |
| Estimated end date | 2025-09-23 |
| Actual end date | 2025-09-12 |
| Shortage status | Resolved |
| Updated date | 2025-09-15 |
| Company comments | Quality Hold |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2025-09-15 | French | Compare |
| v5 | 2025-09-15 | English | Compare |
| v4 | 2025-09-09 | French | Compare |
| v3 | 2025-09-09 | English | Compare |
| v2 | 2025-07-09 | French | Compare |
| v1 | 2025-07-09 | English | Compare |
Showing 1 to 6 of 6